[HTML][HTML] Re-emergence of interferon-α in the treatment of chronic myeloid leukemia

M Talpaz, R Hehlmann, A Quintas-Cardama, J Mercer… - Leukemia, 2013 - nature.com
polymerase chain reaction (PCR) and found that patients who … continuously monitored
BCR-ABL transcript levels by RT–… -positive chronic myelogenous leukemia with interferon-alpha

Molecular monitoring in patients with chronic myelogenous leukemia

G Saglio, S Ulisciani, M Fava, E Gottardi… - Current Hematologic …, 2008 - Springer
… real-time quantitative polymerase chain reaction has become the method … chronic myelogenous
leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction

Molecular monitoring of responses to DLI and DLI+ IFN treatment of post-SCT relapses in patients with CML

J Moravcová, S Nádvornı́ková, V Zmeková… - Leukemia research, 2003 - Elsevier
… -polymerase chain reaction (Q-RT-PCR) monitoring the … and DLI+IFN using quantitative
competitive RT-PCR for BCR-… for the treatment of chronic myelogenous leukemia. Abstract …

[HTML][HTML] Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

TP Hughes, J Kaeda, S Branford… - … England Journal of …, 2003 - Mass Medical Soc
… reverse-transcriptase polymerase chain reaction (PCR) has allowed patients in complete …
RNA and for differences in the efficiency of the reverse-transcriptase reaction. Nested PCR …

… BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-α therapy or allogeneic bone …

JC Chomel, F Brizard, A Veinstein… - Blood, The Journal …, 2000 - ashpublications.org
… -polymerase chain reaction (Q-RT-PCR) methods to study minimal residual disease in 3
patients with CML in … After treatment with IFN-α or allogeneic BMT, the monitoring of the residual …

Use of interferon-α in the treatment of chronic myelogenous leukemia

R Hehlmann, A Reiter - … : Biological Activities and Clinical Efficacy, 1997 - Springer
Polymerase chain reaction (PCR) has been used previously for monitoring patients after …
2 antibody positive CML patients with natural interferon-alpha. Br J Haematol78: 210 67. …

Molecular monitoring 101: helping your patients with chronic myeloid leukemia to understand the meaning of molecular response

EJ Jabbour, A Quintás-Cardama - Leukemia & lymphoma, 2012 - Taylor & Francis
… -time quantitative polymerase chain reaction assessments of … molecular responses and
mutation monitoring. The aim of … (DASISION) demonstrated improved efficacy versus imatinib at …

Molecular Surveillance of Chronic Myeloid Leukemia Patients in the Imatinib Era–Evaluation of Response and Resistance

P Paschka, K Merx, A Hochhaus - Acta haematologica, 2004 - karger.com
chronic myelogenous leukemia patients on interferonalpha therapy by competitive polymerase
chain reaction… J, Arlinghaus R: Quantitative polymerase chain reaction monitoring of BCR-…

Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors

J Ou, JA Vergilio, A Bagg - American journal of hematology, 2008 - Wiley Online Library
… reverse transcriptasepolymerase chain reaction analyses (RT-… pharmacological agents such
as interferon alpha (with or … from the initial use of competitive and limiting dilution RT-PCR …

Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization

NCP Cross, A Hochhaus, MC Müller - Annals of hematology, 2015 - Springer
… by reverse transcription polymerase chain reaction (RT-PCR) were initiated more than 25 …
in complete cytogenetic remission (CCyR) on interferon alpha [7–11]. Competitive PCR was …